Galactosylated liposomes as oligodeoxynucleotides carrier for hepatocyte-selective targeting
Galactosylated liposomes as oligodeoxynucleotides carrier for hepatocyte-selective targeting
复制标题
DOI:
10.1691/ph.2007.7.6232
复制
发表时间:
2007-07-01
期刊:
影响因子:
1.6
通讯作者:
Wang, Siling
中科院分区:
文献类型:
--
作者:
Yu, Fengbo;Jiang, Tongying;Wang, Siling
18mer oligodeoxynucleotides (ODNs) which can inhibit survivin gene expression were selected as a model gene drug. The glycolipid (5-cholestan-3 beta-yl)-1-[2-(lactobionyl amido) ethylamido] formate, (CHE-LA) which specific target to the cells expressing galactose receptors was synthesized through the reaction of lactone of lactobiono-1,5-lactone (LA) and the amino-group of 2-(cholesteryloxycarbonylamino) ethylamine (CHE). The galactosylated liposome incorporated with CHE-LA containing oligodeoxynucleotides was prepared with SPC, cholesterol, CHE-LA and oligodeoxynucleotides by the thin-film hydration method. 1,1'-Dioctadecyl-3,3,3',3'tetramethylindocarbocyanine perchlorate (Dil) was used as a marker for all the liposome preparations. Compared with conventional liposomes (CL), the galactosylated liposomes (GL) exhibited a drastically increased distribution to the liver in vivo and the galactosylated liposomes containing oligodeoxynucleotides (GLO) can also more efficiently induced an apoptosis of HepG2 cells in vitro than the conventional liposome containing oligodeoxynucleotides (CLO). In addition, the GLO represented an improving of the ODNs entrapment efficiency.